Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Caligiuri

Antonio Caligiuri, Parma IT

Patent application numberDescriptionPublished
20100173880ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF - Alkaloid aminoester compounds which act as muscarinic receptor antagonists are useful for the prevention and/or treatment of a broncho-obstructive or inflammatory diseases.07-08-2010

Giuseppina Caligiuri, Paris FR

Patent application numberDescriptionPublished
20110229981DETECTION OF SHED CD31, DIAGNOSIS OF ATHEROTHROMBOSIS AND AUTOIMMUNE DISORDERS, AND METHODS FOR ANALYZING SIGNALING PATHWAYS - The present invention stems from the finding that the extracellular domain of CD31 proteins present on blood leukocytes is shed and released in the circulation as a soluble form of CD31. A method for detecting shed CD31 is further disclosed. The invention therefore relates to a method for detecting a shed ectodomain of a transmembrane protein such as CD31 and to the use of such a method as a diagnostic tool. The invention further provides methods for determining whether a candidate protein is part of a molecular complex.09-22-2011

Marcello Caligiuri, Ferno (varese) IT

Patent application numberDescriptionPublished
20100180716Protection Device with Aerodynamic Effect for a Motor Vehicle - A protection device is described for the ends of a handlebar (M) of a motorcycle, of the type comprising a protection member which can be attached to the ends of said handlebar (M), which comprises a structural protection member (07-22-2010

Maureen Caligiuri, Reading, MA US

Patent application numberDescriptionPublished
20090030067Anti-proliferative combination therapy comprising satraplatin or jm118 and a taxane - The present invention describes a method of prevention and/or treatment of a cancer or a tumor, and in particular a combination therapy, methods, compositions and pharmaceutical packages comprising a taxane and certain platinum-based chemotherapeutic agents.01-29-2009

Michael A. Caligiuri, Columbus, OH US

Patent application numberDescriptionPublished
20080206205Cd34(+) Cells And Their Methods Of Use08-28-2008
20080299660Methods For Transfecting Natural Killer Cells - Methods for stably transfecting mammalian natural killer cells comprising: transfecting a packaging cell line with a retroviral expression vector; culturing the transfected packaging cell line in a cell culture medium; and culturing the mammalian natural killer cells with the cell culture medium. Natural killer cells transfected according to the disclosed methods are also provided.12-04-2008
20090004182Methods to Treat or Prevent Viral-Associated Lymphoproliferative Disorders - The disclosure relates to methods to prevent, treat, or slow the progression viral-associated lymphoproliferative disorders, EBV-associated lymphoproliferative disorders, and post-transplant lymphoproliferative disorders. In the methods, a TGF-β antagonist, e.g., an anti-TGF-β antibody is administered to a subject. Methods for treating viral-associated lymphoproliferative disorders and for enhancing T-cell responsiveness to a viral-associated lymphoproliferative disorder by administering a TGF-β antagonist are also described.01-01-2009

Patent applications by Michael A. Caligiuri, Columbus, OH US